John McCoy
President bij CARDIOVASCULAR SYSTEMS, INC.
Vermogen: 2 M $ op 31-05-2024
Actieve functies van John McCoy
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CARDIOVASCULAR SYSTEMS, INC. | President | - | - |
| Treasurer | - | - | |
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 01-09-2023 | - |
| Corporate Officer/Principal | 01-01-2018 | 01-01-2021 | |
| Treasurer | 01-01-2021 | 01-09-2023 |
Loopbaan van John McCoy
Eerdere bekende functies van John McCoy
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BAXALTA INC | Comptroller/Controller/Auditor | 01-06-2015 | 01-01-2016 |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
| President | 1 |
Sectoraal
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Cardiovascular Systems, Inc.
 Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN. | Health Technology |
- Beurs
- Insiders
- John McCoy
- Ervaring
